Carmignac Gestion’s Day One Biopharmaceuticals DAWN Stock Holding History

Carmignac Gestion’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,691	Closed	-$294K	–	109
2026 Q1	$294K	Buy	+13,691	New	+$193K	﹤0.01%	107

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Carmignac Gestion's DAWN Position: Q2 2026 in Review

Carmignac Gestion sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 13,691 shares — an estimated $294K sold.

Carmignac Gestion first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $294K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Carmignac Gestion reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Carmignac Gestion sold 13,691 Day One Biopharmaceuticals shares in Q2 2026, an estimated $294K.
Carmignac Gestion first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Carmignac Gestion's Day One Biopharmaceuticals position peaked at $294K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Carmignac Gestion's 13F filing for Q2 2026, filed 13 Aug 2026.